Combined oral contraceptives plus spironolactone compared with metformin in women with polycystic ovary syndrome: a one-year randomized clinical trial

Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome

(2017) Dorte Glintborg et al.   Endocrine Connections

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 1

(2015) Neil F. Goodman et al.   Endocrine Practice

Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis

(2015) Negar Naderpoor et al.   HUMAN REPRODUCTION UPDATE

European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire

(2014) Gerard Conway et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

(2014) Gerard Conway et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Body Composition Is Improved During 12 Months' Treatment With Metformin Alone or Combined With Oral Contraceptives Compared With Treatment With Oral Contraceptives in Polycystic Ovary Syndrome

(2014) Dorte Glintborg et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Polycystic ovary syndrome and combined oral contraceptive use: a comparison of clinical practice in the United States to treatment guidelines

(2013) Steven T. Bird et al.   GYNECOLOGICAL ENDOCRINOLOGY

Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study

(2012) T. Piltonen et al.   HUMAN REPRODUCTION

Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

(2011) Bart C.J.M. Fauser et al.   FERTILITY AND STERILITY

Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society

(2011) H.F. Escobar-Morreale et al.   HUMAN REPRODUCTION UPDATE

Treatment of Polycystic Ovary Syndrome (PCOS) with Metformin Ameliorates Insulin Resistance in Parallel with the Decrease of Serum Interleukin-6 Concentrations

(2010) M. Luque-Ramírez et al.   HORMONE AND METABOLIC RESEARCH

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

(2010) Robert A. Wild et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effects of metformin versus ethinyl-estradiol plus cyproterone acetate on ambulatory blood pressure monitoring and carotid intima media thickness in women with the polycystic ovary syndrome

(2008) Manuel Luque-Ramírez et al.   FERTILITY AND STERILITY

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

(2008) Ricardo Azziz et al.   FERTILITY AND STERILITY

Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin

(2008) M. Luque-Ramirez et al.   HUMAN REPRODUCTION

Metformin for the Treatment of the Polycystic Ovary Syndrome

(2008) John E. Nestler   NEW ENGLAND JOURNAL OF MEDICINE

Antiandrogenic Contraceptives Increase Serum Adiponectin in Obese Polycystic Ovary Syndrome Patients

(2008) Manuel Luque-Ramírez et al.   Obesity

A Prospective Study of the Prevalence of Nonclassical Congenital Adrenal Hyperplasia among Women Presenting with Hyperandrogenic Symptoms and Signs

(2007) Héctor F. Escobar-Morreale et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM